EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pathophysiology, assessment, and treatment of pain in patients with pancreatic ductal adenocarcinoma

Mahya Faghih, Marko Damm, Charlotte Gutzler, Michael Hirth, Marie-Theres Kassik, Louise Kuhlmann, Patrick Michl, Søren S Olesen, Anna E Phillips, Vikesh K Singh, Asbjørn M Drewes

Journal of Gastroenterology · 2026

DOI: 10.1007/s00535-026-02423-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology, 2026. Verfasst von Mahya Faghih und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Cancer Pain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pain is one of the most frequent and debilitating symptoms associated with pancreatic ductal adenocarcinoma (PDAC). More than 60% of patients suffer from significant pain at diagnosis. The prevalence increases during the progression of the disease and is associated with anorexia, weight loss, and impaired social interactions. The pathophysiology of pain includes the combined effects of tumor growth and spread, perineural invasion, neuroimmune interactions, peripheral nerve remodeling, and central nervous system sensitization. Pain is additionally modulated by comorbid conditions, such as anxiety or depression, as well as treatment-related toxicity. Previous reports have used simple unidimensional scales to assess pain intensity, but as pain in PDAC is multidimensional, there is a need to develop new and robust instruments to assess pain. The treatment follows the World Health Organization three-step analgesic ladder. Non-opioid analgesics can be used to improve pain, but strong opioids are often used to relieve pain and suffering. When opioids are used, there should be a focus on the management of the side effects. Patients with anxiety and depression may benefit from treatment with selective serotonin reuptake inhibitors, serotonin/norepinephrine reuptake inhibitors, and tricyclic antidepressants that also have effects on pain. In some cases, more experimental drugs such as ketamine may be used. Celiac plexus neurolysis and local irradiation therapies are supplementary methods used to treat PDAC pain, but the response is unpredictable, and the durability is relatively short. The reduced survival associated with celiac ganglia injection, especially in patients with advanced disease, has also tempered enthusiasm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsCancer PainHumansPain MeasurementAnalgesicsAnalgesics, OpioidPain ManagementDepression

Stichwörter der Autor:innen

Abdominal painNeuroimmunologyPancreatic ductal adenocarcinomaPathophysiology

Substanzen

AnalgesicsAnalgesics, Opioid

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • Department of Internal Medicine I, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Department of Gastroenterology, Hepatology & Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Department of Medicine II, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
  • Centre for Pancreatic Diseases & Mech-Sense, Department of Gastroenterology and Hepatology Clinical Institute, Aalborg University Hospital, Mølleparkvej, 9000, Aalborg, Denmark.
  • Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Zitieren

APA

Faghih, M., Damm, M., Gutzler, C., Hirth, M., Kassik, M. T., Kuhlmann, L., Michl, P., Olesen, S. S., Phillips, A. E., Singh, V. K., & Drewes, A. M. (2026). Pathophysiology, assessment, and treatment of pain in patients with pancreatic ductal adenocarcinoma. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02423-3

Vancouver

Faghih M, Damm M, Gutzler C, Hirth M, Kassik MT, Kuhlmann L, et al. Pathophysiology, assessment, and treatment of pain in patients with pancreatic ductal adenocarcinoma. Journal of Gastroenterology. 2026. doi:10.1007/s00535-026-02423-3

BibTeX
@article{Faghih2026,
  author = {Faghih, Mahya and Damm, Marko and Gutzler, Charlotte and Hirth, Michael and Kassik, Marie-Theres and Kuhlmann, Louise and Michl, Patrick and Olesen, Søren S and Phillips, Anna E and Singh, Vikesh K and Drewes, Asbjørn M},
  title = {Pathophysiology, assessment, and treatment of pain in patients with pancreatic ductal adenocarcinoma},
  journal = {Journal of Gastroenterology},
  year = {2026},
  doi = {10.1007/s00535-026-02423-3}
}
Kostenlos starten →